FIGURE 2.
Inhibition of wtPR3 and its molecular variants I217R and K99L by increasing the amounts of Ac-PYFAP(O-C6H4-4-Cl)2 (compound 3) (A) and Ac-PYDAP(O-C6H4-4-Cl)2 (compound 1) (B) showing the relationship between the S4 and the S2 subsites of PR3.